Page 21 - Learnwell EVS
P. 21
1. A few symptomes and syndromes
ampicillin IV
C hild ren and ad ults: 1 5 0 to 2 0 0 m g/ k g/ d ay in 3 injectio ns (every 8 ho urs) 1
cloxacillin IV
C hild ren: 1 0 0 to 2 0 0 m g/ k g/ d ay in 4 d ivid ed d o ses (every 6 ho urs)
A d ults: 8 to 1 2 g/ d ay in 4 d ivid ed d o ses (every 6 ho urs)
co-amoxiclav (amoxicillin/ clavulanic acid) slo w IV
C hild ren: 7 5 to 1 5 0 m g/ k g/ d ay in 3 d ivid ed d o ses (every 8 ho urs)
A d ults: 3 to 6 g/ d ay in 3 d ivid ed d o ses (every 8 ho urs)
ceftriaxone slo w I V1
C hild ren: 1 0 0 m g/ k g as a single injectio n o n the first d ay , then 5 0 m g/ k g o nce
d aily
A d ults: 2 g o nce d aily
ciprofloxacin P O (by naso gastric tube)
C hild ren: 1 5 to 3 0 m g/ k g/ d ay in 2 d ivid ed d o ses
A d ults: 1 .5 g/ d ay in 2 d ivid ed d o ses
gentamicin I M
C hild ren and ad ults: 3 to 6 m g/ k g o nce d aily o r in 2 d ivid ed d o ses
metronidazole I V
C hild ren: 2 0 to 3 0 m g/ k g/ d ay in 3 d ivid ed d o ses (every 8 ho urs)
A d ults: 1 to 1 .5 g/ d ay in 3 d ivid ed d o ses (every 8 ho urs)
– C o rtico stero id s: no t reco m m end ed , the ad verse effects o utweigh the benefits
Cardiogenic shock
T he o bjective is to resto re efficient card iac o utp ut. T he treatm ent o f card io genic sho ck
d ep end s o n its m echanism .
– Acute left heart failure with pulmonary oedema
A cute p ulm o nary o ed em a (see Heart failure in adults, p age 3 0 9 ).
dInopthame ienveeInIVt o af twaocrosennsitnagntsirgantes bwyithsyvarisncguelapr cuomllapp (se,eubsoe xa pstraogeng2i2no):tro p e:
3 to 1 0 m icro gram s/ k g/ m inute
O nce th e h aem o d y nam ic situatio n allo ws ( no rm al B P , red uctio n in th e signs o f
p erip heral circulato ry failure), nitrates o r m o rp hine m ay be cautio usly intro d uced .
D igo xin sho uld no lo nger be used fo r card io genic sh o ck , excep t in th e rare cases
when a sup raventricular tachy card ia has been d iagno sed by E C G . C o rrect hy p o xia
dbiegfooxirnesulosinwgIVd igo xin.
C hild ren: o ne injectio n o f 0 .0 1 0 m g/ k g ( 1 0 m icro gram s/ k g) , to be rep eated up
to
4 tim es/ 2 4 ho urs if necessary
A d ults: o ne injectio n o f 0 .2 5 to 0 .5 m g, th en 0 .2 5 m g 3 o r 4 tim es/ 2 4 h o urs if
necessary
The solvent of ceftriaxone for IM injection contains lidocaine. Ceftriaxone reconstituted using this solvent must
1
never be administered by IV route. For IV administration, water for injection must always be used.
21
ampicillin IV
C hild ren and ad ults: 1 5 0 to 2 0 0 m g/ k g/ d ay in 3 injectio ns (every 8 ho urs) 1
cloxacillin IV
C hild ren: 1 0 0 to 2 0 0 m g/ k g/ d ay in 4 d ivid ed d o ses (every 6 ho urs)
A d ults: 8 to 1 2 g/ d ay in 4 d ivid ed d o ses (every 6 ho urs)
co-amoxiclav (amoxicillin/ clavulanic acid) slo w IV
C hild ren: 7 5 to 1 5 0 m g/ k g/ d ay in 3 d ivid ed d o ses (every 8 ho urs)
A d ults: 3 to 6 g/ d ay in 3 d ivid ed d o ses (every 8 ho urs)
ceftriaxone slo w I V1
C hild ren: 1 0 0 m g/ k g as a single injectio n o n the first d ay , then 5 0 m g/ k g o nce
d aily
A d ults: 2 g o nce d aily
ciprofloxacin P O (by naso gastric tube)
C hild ren: 1 5 to 3 0 m g/ k g/ d ay in 2 d ivid ed d o ses
A d ults: 1 .5 g/ d ay in 2 d ivid ed d o ses
gentamicin I M
C hild ren and ad ults: 3 to 6 m g/ k g o nce d aily o r in 2 d ivid ed d o ses
metronidazole I V
C hild ren: 2 0 to 3 0 m g/ k g/ d ay in 3 d ivid ed d o ses (every 8 ho urs)
A d ults: 1 to 1 .5 g/ d ay in 3 d ivid ed d o ses (every 8 ho urs)
– C o rtico stero id s: no t reco m m end ed , the ad verse effects o utweigh the benefits
Cardiogenic shock
T he o bjective is to resto re efficient card iac o utp ut. T he treatm ent o f card io genic sho ck
d ep end s o n its m echanism .
– Acute left heart failure with pulmonary oedema
A cute p ulm o nary o ed em a (see Heart failure in adults, p age 3 0 9 ).
dInopthame ienveeInIVt o af twaocrosennsitnagntsirgantes bwyithsyvarisncguelapr cuomllapp (se,eubsoe xa pstraogeng2i2no):tro p e:
3 to 1 0 m icro gram s/ k g/ m inute
O nce th e h aem o d y nam ic situatio n allo ws ( no rm al B P , red uctio n in th e signs o f
p erip heral circulato ry failure), nitrates o r m o rp hine m ay be cautio usly intro d uced .
D igo xin sho uld no lo nger be used fo r card io genic sh o ck , excep t in th e rare cases
when a sup raventricular tachy card ia has been d iagno sed by E C G . C o rrect hy p o xia
dbiegfooxirnesulosinwgIVd igo xin.
C hild ren: o ne injectio n o f 0 .0 1 0 m g/ k g ( 1 0 m icro gram s/ k g) , to be rep eated up
to
4 tim es/ 2 4 ho urs if necessary
A d ults: o ne injectio n o f 0 .2 5 to 0 .5 m g, th en 0 .2 5 m g 3 o r 4 tim es/ 2 4 h o urs if
necessary
The solvent of ceftriaxone for IM injection contains lidocaine. Ceftriaxone reconstituted using this solvent must
1
never be administered by IV route. For IV administration, water for injection must always be used.
21
